Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD
Antonia Sophia Peter, Eva Grüner, Eileen Socher, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8177-8177
Open Access | Times Cited: 10

Showing 10 citing articles:

A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 190
SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
Nina Reuter, Xiaohan Chen, Barbara Kropff, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1500-1500
Open Access | Times Cited: 17
Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model
Christiane Stahl‐Hennig, Antonia Sophia Peter, Arne Cordsmeier, et al.
Journal of Virology (2024) Vol. 98, Iss. 7
Open Access | Times Cited: 2
Prompt-engineering enabled LLM or MLLM and instigative bioinformatics pave the way to identify and characterize the significant SARS-CoV-2 antibody escape mutations
Chiranjib Chakraborty, Manojit Bhattacharya, Soumen Pal, et al.
International Journal of Biological Macromolecules (2024), pp. 138547-138547
Closed Access | Times Cited: 2
Status and Developing Strategies for Neutralizing Monoclonal Antibody Therapy in the Omicron Era of COVID-19
Zuning Ren, Chenguang Shen, Jie Peng
Viruses (2023) Vol. 15, Iss. 6, pp. 1297-1297
Open Access | Times Cited: 5
Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2
Jannik T. Wagner, Sandra M. Müller-Schmucker, Wenjun Wang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Structural insight into broadening SARS-CoV-2 neutralization by an antibody cocktail harboring both NTD and RBD potent antibodies
Wen-ling Jiang, Yanan Jiang, Hui Sun, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access
Exploring B-cell Epitope Conservation and Antigenicity Shift in Current COVID-19 Variants: Analyzing Spike-Antibody Interactions for Therapeutic Uses
Alankar Roy, Ishani Paul, T. Manna Paul, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 739, pp. 150948-150948
Closed Access
SARS-CoV-2: Advances in Serological Methods and the Understanding of Antibody Escape
Daniele Focosi, Fabrizio Maggi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2488-2488
Open Access
Propagation of SARS-CoV-2 in a Closed Cell Culture Device: Potential GMP Compatible Production Platform for Live-Attenuated Vaccine Candidates under BSL-3 Conditions?
Stephan Klessing, Antonia Sophia Peter, Kirsten Fraedrich, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 397-397
Open Access
Page 1

Scroll to top